Related Experiment Videos
Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes.
Patrick Warnat1, Roland Eils, Benedikt Brors
1Department of Theoretical Bioinformatics, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. p.warnat@dkfz.de
BMC Bioinformatics
|November 8, 2005
Summary
Integrating diverse cancer microarray data improves classification accuracy. This cross-platform approach identifies robust gene expression signatures missed in single-study analyses, enhancing predictive model generalization.
Area of Science:
- Genomics
- Bioinformatics
- Cancer Research
Background:
- Extensive use of DNA microarray technology generates vast amounts of cancer transcriptome data.
- Comparative analysis of cancer microarray studies is hindered by heterogeneous platforms and analysis methods.
Purpose of the Study:
- To directly integrate raw microarray data from different studies for supervised classification.
- To overcome limitations of meta-analysis by enabling cross-platform data integration.
Main Methods:
- Developed a method using median rank scores and quantile discretization for numerically comparable gene expression measures.
- Employed support vector machines for training classifiers on transformed, cross-platform data.
- Applied the approach to six cancer microarray datasets (breast, prostate, leukemia) from different platforms (cDNA, oligonucleotide).
Main Results:
- Achieved high classification accuracies (>85%) in cross-validation analyses using integrated data from paired studies.
- Demonstrated successful cross-platform classification for breast cancer, prostate cancer, and acute myeloid leukemia.
- Identified leukemia-specific genes in an integrated analysis that were missed in single-dataset analyses.
Conclusions:
- Cross-platform classification generates robust, validated gene expression signatures across diverse microarray data.
- Predictive models built with integrated data show improved validation, high predictive power, and better generalization.
- This approach enhances the reliability and discovery potential of cancer microarray data analysis.